Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: SGLT2 Inhibition and Left Ventricular Mass [Phase 4]
Phase 4 clinical trial update on SGLT2 inhibition and left ventricular mass in type 2 diabetes, currently terminated.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention [Phase 4]
A Phase 4 trial comparing ticagrelor to clopidogrel for platelet inhibition in type 2 diabetes patients after elective PCI has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01 [Phase 1]
Phase 1 trial investigating GLWL-01 in type 2 diabetes was terminated; results posted previously.
-
CLINICAL_TRIALS withdrawal · 2019-03-20Clinical Trial Update: Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients [Phase 4]
A Phase 4 trial comparing cardiovascular outcomes of pioglitazone and metformin in type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy [Phase 2]
Phase 2 trial comparing a tablet formulation of NNC0123-0000-0338 with insulin glargine in adults with Type 2 diabetes on oral antidiabetic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients [Phase 4]
Phase 4 trial update evaluating the therapeutic efficacy of a triple combination in drug-naïve Korean patients with Type 2 Diabetes.
-
CLINICAL_TRIALS withdrawal · 2019-03-18Clinical Trial Update: Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes [Phase 4]
A Phase 4 trial investigating prevention of type 2 diabetes after gestational diabetes was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment [Phase 3]
Phase 3 trial updating results comparing insulin peglispro with insulin glargine as basal insulin in type 2 diabetes mellitus; study complet…
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 long-term safety study of canagliflozin (TA-7284) in combination with insulin for type 2 diabetes mellitus has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 long-term safety study evaluating the combination of canagliflozin with a GLP-1 analogue in adults with type 2 diabetes mellitus has…
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Hyperbaric Oxygen Therapy as Adjunctive Therapy to Scaling and Root-planing in the Management of Periodontitis in Patients With Type 2 Diabetes [NA]
A terminated clinical trial evaluated hyperbaric oxygen therapy as an adjunct to scaling and root planing for periodontitis in patients with…
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs [Phase 3]
This Phase 3 trial compared insulin degludec/liraglutide versus insulin degludec, each in combination with metformin, in Japanese patients w…
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: Diabetes and Gastric By- Pass
A completed clinical trial (NCT01153516) investigating diabetes in the context of gastric bypass surgery, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin [Phase 3]
A Phase 3 trial comparing ITCA 650 as add-on to metformin against empagliflozin and glimepiride; study terminated with results and safety/to…
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c [Phase 3]
A Phase 3 clinical trial investigating ITCA 650 for type 2 diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: The Effects of LY2409021 on the Liver [Phase 1]
Phase 1 trial update assessing effects of LY2409021 on the liver in type 2 diabetes patients; study completed with results posted.
-
FDA approval · 2019-03-06FDA Approved: PIOGLITAZONE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Pioglitazone and Metformin Hydrochloride (Macleods Pharmaceuticals Limited). This fixed-dose com…
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial update evaluating the addition of albiglutide to standard glucose-lowering therapies and its effect on major cardiovascular ev…
-
CLINICAL_TRIALS trial_result · 2019-03-04Clinical Trial Update: Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus [Phase 4]
A Phase 4 trial evaluating the efficacy and safety of Subetta as part of a combined treatment for Type II diabetes mellitus has completed en…
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia [Phase 4]
Phase 4 trial update on azilsartan medoxomil for essential hypertension and type 2 diabetes mellitus completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: The Efficacy of Bariatric Surgery Compared to Medical Therapy in Controlling Type2 Diabetes Mellitus in Patients With Non Morbid Obesity. [Phase 2, Phase 3]
A clinical trial evaluating bariatric surgery versus medical therapy for controlling type 2 diabetes in overweight individuals; current stat…
-
FDA approval · 2019-03-01FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for metformin hydrochloride submitted by Sun Pharmaceutical Industries, Inc., confirming/adding appr…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848) [Phase 3]
Phase 3 trial evaluating sitagliptin added during metformin up-titration in adults with type 2 diabetes; completed with results posted in 20…
-
FDA approval · 2019-02-27FDA Approved: XULTOPHY 100/3.6 — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application to add the XULTOPHY 100/3.6 strength, a fixed-ratio combination of insulin degludec and liraglut…
-
FDA approval · 2019-02-27FDA Approved: SOLIQUA 100/33 — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Soliqua 100/33 (insulin glargine and lixisenatide) from Sanofi-Aventis U.S. LLC.